29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neuroinflammation and Neuroimmune Dysregulation after Acute Hypoxic-Ischemic Injury of Developing Brain

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hypoxic-ischemic (HI) injury to developing brain results from birth asphyxia in neonates and from cardiac arrest in infants and children. It is associated with varying degrees of neurologic sequelae, depending upon the severity and length of HI. Global HI triggers a series of cellular and biochemical pathways that lead to neuronal injury. One of the key cellular pathways of neuronal injury is inflammation. The inflammatory cascade comprises activation and migration of microglia – the so-called “brain macrophages,” infiltration of peripheral macrophages into the brain, and release of cytotoxic and proinflammatory cytokines. In this article, we review the inflammatory and immune mechanisms of secondary neuronal injury after global HI injury to developing brain. Specifically, we highlight the current literature on microglial activation in relation to neuronal injury, proinflammatory and anti-inflammatory/restorative pathways, the role of peripheral immune cells, and the potential use of immunomodulators as neuroprotective compounds.

          Related collections

          Most cited references158

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular characterization of a peripheral receptor for cannabinoids.

          The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

            Microglia are the resident CNS immune cells and active surveyors of the extracellular environment. While past work has focused on the role of these cells during disease, recent imaging studies reveal dynamic interactions between microglia and synaptic elements in the healthy brain. Despite these intriguing observations, the precise function of microglia at remodeling synapses and the mechanisms that underlie microglia-synapse interactions remain elusive. In the current study, we demonstrate a role for microglia in activity-dependent synaptic pruning in the postnatal retinogeniculate system. We show that microglia engulf presynaptic inputs during peak retinogeniculate pruning and that engulfment is dependent upon neural activity and the microglia-specific phagocytic signaling pathway, complement receptor 3(CR3)/C3. Furthermore, disrupting microglia-specific CR3/C3 signaling resulted in sustained deficits in synaptic connectivity. These results define a role for microglia during postnatal development and identify underlying mechanisms by which microglia engulf and remodel developing synapses. Copyright © 2012 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Control of microglial neurotoxicity by the fractalkine receptor.

              Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/60623
                URI : http://frontiersin.org/people/u/12534
                URI : http://frontiersin.org/people/u/143994
                Journal
                Front Pediatr
                Front Pediatr
                Front. Pediatr.
                Frontiers in Pediatrics
                Frontiers Media S.A.
                2296-2360
                14 January 2015
                2014
                : 2
                : 144
                Affiliations
                [1] 1Department of Anesthesiology, Johns Hopkins University School of Medicine , Baltimore, MD, USA
                [2] 2Department of Critical Care Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA
                Author notes

                Edited by: Hitesh Singh Sandhu, The University of Tennessee Health Science Center, USA

                Reviewed by: Jhuma Sankar, All India Institute of Medical Sciences, India; Michael Shoykhet, Washington University in St. Louis School of Medicine, USA

                *Correspondence: Utpal S. Bhalala, Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Bloomberg Children’s Center, 1800 Orleans Street, Suite 6349B, Baltimore, MD 21287, USA e-mail: ubhalal1@ 123456jhmi.edu

                This article was submitted to Pediatric Critical Care, a section of the journal Frontiers in Pediatrics.

                Article
                10.3389/fped.2014.00144
                4294124
                25642419
                b9c2b17d-121c-4cd8-80ca-e136f9834acf
                Copyright © 2015 Bhalala, Koehler and Kannan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 03 November 2014
                : 22 December 2014
                Page count
                Figures: 2, Tables: 1, Equations: 0, References: 195, Pages: 12, Words: 11352
                Categories
                Pediatrics
                Review Article

                hypoxia-ischemic encephalopathy,inflammation,developing brain,microglia,immune dysregulation

                Comments

                Comment on this article